FDA Inspection 1073182 — Cipla, Ltd.
The FDA completed an inspection of Cipla, Ltd. on November 30, 2018 in Kurkumbh Village, Dist. Pune. The inspection was classified NAI (No Action Indicated — no objectionable conditions were found). Product area: Drugs.
Inspection Details
- Classification
- No Action Indicated (NAI) (NAI)
- End Date
- November 30, 2018
- Fiscal Year
- 2019
- Product Type
- Drugs
- Project Area
- Drug Quality Assurance
- Location
- Kurkumbh Village, Dist. Pune (India)